🇺🇸 FDA
Patent

US 9649364

Methods for producing stable therapeutic formulations in aprotic polar solvents

granted A61KA61K38/00A61K38/26

Quick answer

US patent 9649364 (Methods for producing stable therapeutic formulations in aprotic polar solvents) held by XERIS PHARMACEUTICALS, INC. expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
XERIS PHARMACEUTICALS, INC.
Grant date
Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61K38/26, A61K47/00, A61K47/02